Structure of HDL: particle subclasses and molecular components.

[1]  K. Hovingh,et al.  ApoA‐I mutations, L202P and K131del, in HDL from heterozygotes with low HDL‐C , 2014, Proteomics. Clinical applications.

[2]  A. von Eckardstein,et al.  High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. , 2014, Circulation research.

[3]  A. Nègre-Salvayre,et al.  Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids: Relevance to Cellular Cholesterol Efflux, Antioxidative, Antithrombotic, Anti-Inflammatory, and Antiapoptotic Functionalities , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[4]  B. Fagerberg,et al.  Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles. , 2013, Biochimica et biophysica acta.

[5]  J. Segrest,et al.  MD simulations suggest important surface differences between reconstituted and circulating spherical HDL1[S] , 2013, Journal of Lipid Research.

[6]  Amy S. Shah,et al.  Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond1 , 2013, Journal of Lipid Research.

[7]  O. Gursky,et al.  Structural basis for distinct functions of the naturally occurring Cys mutants of human apolipoprotein A-I[S] , 2013, Journal of Lipid Research.

[8]  Jingyuan Deng,et al.  Multi-dimensional Co-separation Analysis Reveals Protein–Protein Interactions Defining Plasma Lipoprotein Subspecies* , 2013, Molecular & Cellular Proteomics.

[9]  L. Mayne,et al.  Comparison of apoA-I helical structure and stability in discoidal and spherical HDL particles by HX and mass spectrometry , 2013, Journal of Lipid Research.

[10]  S. Nicolardi,et al.  Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera. , 2013, Journal of proteome research.

[11]  S. Nicolardi,et al.  Mapping O‐glycosylation of apolipoprotein C‐III in MALDI‐FT‐ICR protein profiles , 2013, Proteomics.

[12]  Naidong Weng,et al.  Relative quantitation of glycoisoforms of intact apolipoprotein C3 in human plasma by liquid chromatography-high-resolution mass spectrometry. , 2013, Analytical chemistry.

[13]  G. Larson,et al.  LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins. , 2013, Journal of proteome research.

[14]  O. Gursky.  Crystal structure of Δ(185-243)ApoA-I suggests a mechanistic framework for the protein adaptation to the changing lipid load in good cholesterol: from flatland to sphereland via double belt, belt buckle, double hairpin and trefoil/tetrafoil. , 2013, Journal of molecular biology.

[15]  M. Phillips.  New insights into the determination of HDL structure by apolipoproteins1 , 2012, Journal of Lipid Research.

[16]  K. Ekroos.  Lipidomics: Technologies and Applications , 2012 .

[17]  A. Kontush,et al.  Lipidomics in Lipoprotein Biology , 2012 .

[18]  T. Kasama,et al.  Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion , 2012, Bioscience reports.

[19]  Jonathan D. Stallings,et al.  Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach* , 2012, Molecular & Cellular Proteomics.

[20]  J. Baenziger.  Moving the O-glycoproteome from form to function , 2012, Proceedings of the National Academy of Sciences.

[21]  H. Wandall,et al.  Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells , 2012, Proceedings of the National Academy of Sciences.

[22]  Hojoong Kim,et al.  Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera. , 2012, Journal of proteomics.

[23]  Baohai Shao.  Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. , 2012, Biochimica et biophysica acta.

[24]  P. Manley,et al.  Acute-phase serum amyloid A: Perspectives on its physiological and pathological roles , 2012, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[25]  A. Kontush,et al.  High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics , 2012 .

[26]  A. Zwinderman,et al.  Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. , 2011, Cell metabolism.

[27]  A. Kontush,et al.  Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.

[28]  D. Atkinson,et al.  Crystal Structure of C-terminal Truncated Apolipoprotein A-I Reveals the Assembly of High Density Lipoprotein (HDL) by Dimerization* , 2011, The Journal of Biological Chemistry.

[29]  K. Matsuda,et al.  Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum. , 2011, Journal of immunological methods.

[30]  K. Pecankova,et al.  Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1 , 2011, Journal of Translational Medicine.

[31]  A. Chait,et al.  Serum Amyloid A Facilitates the Binding of High-Density Lipoprotein From Mice Injected With Lipopolysaccharide to Vascular Proteoglycans , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[32]  B. Dahlbäck,et al.  Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M , 2011, Proceedings of the National Academy of Sciences.

[33]  C. Lipina,et al.  Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance , 2011, Diabetologia.

[34]  D. Rader,et al.  Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice. , 2011, Biochimica et biophysica acta.

[35]  Feifei Gu,et al.  "Sticky" and "promiscuous", the yin and yang of apolipoprotein A-I termini in discoidal high-density lipoproteins: a combined computational-experimental approach. , 2011, Biochemistry.

[36]  G. Ghiggeri,et al.  Protein-protein interaction heterogeneity of plasma apolipoprotein A1 in nephrotic syndrome. , 2011, Molecular bioSystems.

[37]  R. Krauss,et al.  HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. , 2011, Clinical chemistry.

[38]  S. Hazen,et al.  The Low Resolution Structure of ApoA1 in Spherical High Density Lipoprotein Revealed by Small Angle Neutron Scattering* , 2011, The Journal of Biological Chemistry.

[39]  Gerd Schmitz,et al.  Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry. , 2011, Biochimica et biophysica acta.

[40]  Scott M. Gordon,et al.  High density lipoprotein: it's not just about lipid transport anymore , 2011, Trends in Endocrinology & Metabolism.

[41]  K. Weisgraber,et al.  Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy , 2011, Journal of Lipid Research.

[42]  L. Curtiss,et al.  Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma , 2010, Nature Structural &Molecular Biology.

[43]  P. Geurts,et al.  High-density lipoprotein proteome dynamics in human endotoxemia , 2011, Proteome Science.

[44]  B. Nordestgaard,et al.  S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease , 2011, Lipids in Health and Disease.

[45]  H. Pownall,et al.  Speciated human high-density lipoprotein protein proximity profiles. , 2010, Biochemistry.

[46]  G. Lambeau,et al.  Lipoprotein-Associated and Secreted Phospholipases A2 in Cardiovascular Disease: Roles as Biological Effectors and Biomarkers , 2010, Circulation.

[47]  D. Rateri,et al.  Impact of serum amyloid A on high density lipoprotein composition and levels , 2010, Journal of Lipid Research.

[48]  J. Segrest,et al.  Assessment of the Validity of the Double Superhelix Model for Reconstituted High Density Lipoproteins , 2010, The Journal of Biological Chemistry.

[49]  Jingyuan Deng,et al.  Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. , 2010, Journal of proteome research.

[50]  M. Nakano,et al.  Static and dynamic characterization of nanodiscs with apolipoprotein A-I and its model peptide. , 2010, The journal of physical chemistry. B.

[51]  Xianlin Han,et al.  Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation. , 2010, Biochemistry.

[52]  S. Hazen,et al.  Congruency between biophysical data from multiple platforms and molecular dynamics simulation of the double-super helix model of nascent high-density lipoprotein. , 2010, Biochemistry.

[53]  A. Kontush,et al.  Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities , 2010, Current opinion in lipidology.

[54]  E. Schaefer,et al.  Marked HDL deficiency and premature coronary heart disease , 2010, Current opinion in lipidology.

[55]  R. Erbel,et al.  Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease , 2010, Basic Research in Cardiology.

[56]  K. Nair,et al.  Identification of De Novo Synthesized and Relatively Older Proteins , 2010, Diabetes.

[57]  J. Joven,et al.  Human tissue distribution of paraoxonases 1 and 2 mRNA , 2010, IUBMB life.

[58]  B. Levkau,et al.  Endothelial Functions of Sphingosine-1-phosphate , 2010, Cellular Physiology and Biochemistry.

[59]  Daniel S Spellman,et al.  Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry , 2010, Proceedings of the National Academy of Sciences.

[60]  Ju Yong Lee,et al.  Profiling of phospholipids in lipoproteins by multiplexed hollow fiber flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry. , 2010, Journal of chromatography. A.

[61]  Ki-yong Kim,et al.  Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence. , 2010, Biochemical and biophysical research communications.

[62]  M. Olivier,et al.  Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry. , 2010, Physiological genomics.

[63]  B. Fagerberg,et al.  Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[64]  K. Weisgraber,et al.  Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy , 2010 .

[65]  M. Phillips,et al.  High density lipoprotein structure-function and role in reverse cholesterol transport. , 2010, Sub-cellular biochemistry.

[66]  N. Gupta,et al.  Paraoxonase: a multifaceted biomolecule. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[67]  O. Ryder,et al.  Mass spectral analyses of the two major apolipoproteins of great ape high density lipoproteins. , 2009, Comparative biochemistry and physiology. Part D, Genomics & proteomics.

[68]  H. Shimano.  ApoAII controversy still in rabbit? , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[69]  M. Couturier,et al.  HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and Atherogenesis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[70]  Feifei Gu,et al.  Structures of Discoidal High Density Lipoproteins , 2009, The Journal of Biological Chemistry.

[71]  B. Dahlbäck,et al.  Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M. , 2009, Journal of molecular biology.

[72]  Weidong Zhou,et al.  An initial characterization of the serum phosphoproteome. , 2009, Journal of proteome research.

[73]  S. Hazen,et al.  Double Superhelix Model of High Density Lipoprotein* , 2009, The Journal of Biological Chemistry.

[74]  Andrew N Hoofnagle,et al.  Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins , 2009, Journal of Lipid Research.

[75]  A. Burlingame,et al.  HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  A. Kontush,et al.  Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[77]  H. Lindqvist,et al.  Protein profiling of low‐density lipoprotein from obese subjects , 2009, Proteomics. Clinical applications.

[78]  S. Mora.  Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use. , 2009, Circulation.

[79]  T. Vaisar,et al.  Thematic Review Series: Proteomics. Proteomic analysis of lipid-protein complexes Published, JLR Papers in Press, February 19, 2009. , 2009, Journal of Lipid Research.

[80]  J. Heinecke.  The HDL proteome: a marker–and perhaps mediator–of coronary artery disease Published, JLR Papers in Press, December 5, 2008. , 2009, Journal of Lipid Research.

[81]  A. Remaley,et al.  Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease. , 2009, Current opinion in endocrinology, diabetes, and obesity.

[82]  M. Wróblewska,et al.  Phospholipids mediated conversion of HDLs generates specific apoA-II pre-beta mobility particles. , 2009, Journal of lipid research.

[83]  D. Stafforini,et al.  The emerging roles of PAF acetylhydrolase This work was supported by National Institutes of Health Grants HL44513, HL35828, and HL087018. Published, JLR Papers in Press, October 6, 2008. , 2009, Journal of Lipid Research.

[84]  H. Korswagen,et al.  Mammalian Wnt3a is Released on Lipoprotein Particles , 2009, Traffic.

[85]  G. Bernard,et al.  O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. , 2009, Journal of proteome research.

[86]  B. Dahlbäck,et al.  Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation? , 2009, Cellular and Molecular Life Sciences.

[87]  D. Rader,et al.  Overexpression of Apolipoprotein F Reduces HDL Cholesterol Levels In Vivo , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[88]  V. Drouin‐Garraud,et al.  Two dimensional gel electrophoresis of apolipoprotein C‐III and MALDI‐TOF MS are complementary techniques for the study of combined defects in N‐ and mucin type O‐glycan biosynthesis , 2008 .

[89]  Zeyu Jiang,et al.  ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death , 2008, Autophagy.

[90]  J. Wands,et al.  Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis. , 2008, Journal of hepatology.

[91]  Jianwen Fang,et al.  Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes , 2008, Proceedings of the National Academy of Sciences.

[92]  B. Dahlbäck,et al.  The Signal Peptide Anchors Apolipoprotein M in Plasma Lipoproteins and Prevents Rapid Clearance of Apolipoprotein M from Plasma* , 2008, Journal of Biological Chemistry.

[93]  L. Wehenkel,et al.  Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. , 2008, Clinical chemistry.

[94]  Perttu S. Niemelä,et al.  Structure of spheroidal HDL particles revealed by combined atomistic and coarse-grained simulations. , 2008, Biophysical journal.

[95]  B. Dahlbäck,et al.  Apolipoprotein M associates to lipoproteins through its retained signal peptide , 2008, FEBS letters.

[96]  G. Bernard,et al.  Top‐down proteomic analysis by MALDI‐TOF profiling: Concentration‐independent biomarkers , 2008, PROTEOMICS - Clinical Applications.

[97]  G. Ghiggeri,et al.  High‐resolution 2‐DE for resolving proteins, protein adducts and complexes in plasma , 2008, Electrophoresis.

[98]  E. Schaefer,et al.  Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. , 2007, The American journal of cardiology.

[99]  G. Franceschini,et al.  Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients. , 2007, Atherosclerosis.

[100]  S. Hazen,et al.  The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction , 2007, Nature Structural &Molecular Biology.

[101]  B. Dahlbäck,et al.  Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M Published, JLR Papers in Press, May 24, 2007. , 2007, Journal of Lipid Research.

[102]  M. Couturier,et al.  Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[103]  B. Dahlbäck,et al.  An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma Published, JLR Papers in Press, May 25, 2007. , 2007, Journal of Lipid Research.

[104]  S. Yamashita,et al.  Role of LCAT in HDL remodeling: investigation of LCAT deficiency states Published, JLR Papers in Press, December 20, 2006. , 2007, Journal of Lipid Research.

[105]  Subramaniam Pennathur,et al.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.

[106]  G. Franceschini,et al.  A Unique Protease-sensitive High Density Lipoprotein Particle Containing the Apolipoprotein A-IMilano Dimer Effectively Promotes ATP-binding Cassette A1-mediated Cell Cholesterol Efflux* , 2007, Journal of Biological Chemistry.

[107]  Ing-Kae Wang,et al.  Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules , 2007, Nature Structural &Molecular Biology.

[108]  P. Barter,et al.  The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase , 2007, Diabetologia.

[109]  P. Rouet,et al.  ApoO, a Novel Apolipoprotein, Is an Original Glycoprotein Up-regulated by Diabetes in Human Heart* , 2006, Journal of Biological Chemistry.

[110]  K. Weisgraber,et al.  Apolipoprotein E structure: insights into function. , 2006, Trends in biochemical sciences.

[111]  J. Voss,et al.  Apolipoprotein A-I Assumes a “Looped Belt” Conformation on Reconstituted High Density Lipoprotein* , 2006, Journal of Biological Chemistry.

[112]  N. Bergeron,et al.  Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism Published, JLR Papers in Press, February 22, 2006. , 2006, Journal of Lipid Research.

[113]  G. Hortin,et al.  Diverse range of small peptides associated with high-density lipoprotein. , 2006, Biochemical and biophysical research communications.

[114]  A. Nilsson,et al.  Absorption and lipoprotein transport of sphingomyelin Published, JLR Papers in Press, October 26, 2005. , 2006, Journal of Lipid Research.

[115]  H. Brewer,et al.  The composition and metabolism of high density lipoprotein subfractions , 1979, Lipids.

[116]  A. Scanu.  Ultrastructure of serum high density lipoproteins: Facts and models , 1978, Lipids.

[117]  Shelly C. Lu,et al.  Oxidation of specific methionine and tryptophan residues of apolipoprotein A‐I in hepatocarcinogenesis , 2005, Proteomics.

[118]  Michael J. Thomas,et al.  Intermolecular Contact between Globular N-terminal Fold and C-terminal Domain of ApoA-I Stabilizes Its Lipid-bound Conformation , 2005, Journal of Biological Chemistry.

[119]  S. Hajduk,et al.  Human High Density Lipoproteins Are Platforms for the Assembly of Multi-component Innate Immune Complexes* , 2005, Journal of Biological Chemistry.

[120]  T. Manabe,et al.  Direct targeting of human plasma for matrix‐assisted laser desorption/ionization and analysis of plasma proteins by time of flight‐mass spectrometry , 2005, Electrophoresis.

[121]  George M. Hilliard,et al.  A mass spectrometric determination of the conformation of dimeric apolipoprotein A-I in discoidal high density lipoproteins. , 2005, Biochemistry.

[122]  Per Leanderson,et al.  Lipoproteomics II: Mapping of proteins in high‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry , 2005, Proteomics.

[123]  M. N. Poy,et al.  Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis , 2005, Nature Medicine.

[124]  J. B. Massey,et al.  Plasma factors required for human apolipoprotein A-II dimerization. , 2005, Biochemistry.

[125]  W. Gross,et al.  Distribution spectrum of paraoxonase activity in HDL fractions. , 2004, Clinical chemistry.

[126]  R. Jandacek,et al.  Identification and structural ramifications of a hinge domain in apolipoprotein A-I discoidal high-density lipoproteins of different size. , 2004, Biochemistry.

[127]  Kenneth R Feingold,et al.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. , 2004, Journal of lipid research.

[128]  Aldons J Lusis,et al.  Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL , 2004, Journal of Lipid Research.

[129]  Dan S. Tawfik,et al.  Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes , 2004, Nature Structural &Molecular Biology.

[130]  G. Franceschini,et al.  Depletion of Pre-β-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein* , 2004, Journal of Biological Chemistry.

[131]  G. Getz,et al.  Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro Published, JLR Papers in Press, November 1, 2003. DOI 10.1194/jlr.M300414-JLR200 , 2004, Journal of Lipid Research.

[132]  G. Franceschini,et al.  Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. , 2004, The Journal of biological chemistry.

[133]  S. Tam,et al.  Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1 Published, JLR Papers in Press, September 1, 2003. DOI 10.1194/jlr.M300133-JLR200 , 2003, Journal of Lipid Research.

[134]  R. Wevers,et al.  Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. , 2003, Clinical chemistry.

[135]  A. Kontush,et al.  Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[136]  W. Davidson,et al.  The Spatial Organization of Apolipoprotein A-I on the Edge of Discoidal High Density Lipoprotein Particles , 2003, Journal of Biological Chemistry.

[137]  E. Schaefer,et al.  High-density lipoprotein subpopulations in pathologic conditions. , 2003, The American journal of cardiology.

[138]  R. Maeba,et al.  Ethanolamine plasmalogen and cholesterol reduce the total membrane oxidizability measured by the oxygen uptake method. , 2003, Biochemical and biophysical research communications.

[139]  E. Schaefer,et al.  HDL in atherosclerosis: actor or bystander? , 2003, Atherosclerosis. Supplements.

[140]  T. Miida,et al.  Analytical performance of a sandwich enzyme immunoassay for pre beta 1-HDL in stabilized plasma. , 2003, Journal of lipid research.

[141]  G. Franceschini,et al.  Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux. , 2003, Journal of lipid research.

[142]  R. Nelson,et al.  Detection of novel truncated forms of human serum amyloid A protein in human plasma , 2003, FEBS letters.

[143]  D. Vance,et al.  Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .

[144]  Anthony E. Klon,et al.  Molecular dynamics simulations on discoidal HDL particles suggest a mechanism for rotation in the apo A-I belt model. , 2002, Journal of molecular biology.

[145]  Hui-hua Li,et al.  ApoA-I Structure on Discs and Spheres , 2002, The Journal of Biological Chemistry.

[146]  S. Harvey,et al.  Comparative models for human apolipoprotein A-I bound to lipid in discoidal high-density lipoprotein particles. , 2002, Biochemistry.

[147]  L. Holmquist.  Selective extraction of lecithin:cholesterol acyltransferase (EC 2.3.1.43) from human plasma. , 2002, Journal of biochemical and biophysical methods.

[148]  W. Davidson,et al.  Apolipoprotein A-I Adopts a Belt-like Orientation in Reconstituted High Density Lipoproteins* , 2001, The Journal of Biological Chemistry.

[149]  Y. Marcel,et al.  Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL. , 2001, Journal of lipid research.

[150]  J. Engler,et al.  Structural models of human apolipoprotein A-I: a critical analysis and review. , 2001, Biochimica et biophysica acta.

[151]  F. Lee,et al.  ISOLATION AND PARTIAL CHARACTERIZATION OF APOLIPOPROTEIN D : A NEW PROTEIN MOIETY OF THE HUMAN PLASMA LIPOPROTEIN SYSTEM , 2001 .

[152]  D. Lyles,et al.  Structural Determination of Lipid-bound ApoA-I Using Fluorescence Resonance Energy Transfer* , 2000, The Journal of Biological Chemistry.

[153]  S. Harvey,et al.  Detailed molecular model of apolipoprotein A-I on the surface of high-density lipoproteins and its functional implications. , 2000, Trends in cardiovascular medicine.

[154]  T. Sasaki,et al.  Inhibition of lipoprotein lipase activity by sphingomyelin: role of membrane surface structure. , 2000, Biochimica et biophysica acta.

[155]  M. Krieger,et al.  Binding of High Density Lipoprotein (HDL) and Discoidal Reconstituted HDL to the HDL Receptor Scavenger Receptor Class B Type I* , 2000, The Journal of Biological Chemistry.

[156]  J. Holtzman,et al.  Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides. , 2000, The Journal of laboratory and clinical medicine.

[157]  W. Pruzanski,et al.  Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. , 2000, Journal of lipid research.

[158]  José A Fernández,et al.  Cardiolipin is a normal component of human plasma lipoproteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[159]  H. Jakubowski.  Calcium-dependent Human Serum Homocysteine Thiolactone Hydrolase , 2000, The Journal of Biological Chemistry.

[160]  E. Rassart,et al.  Apolipoprotein D. , 2000, Biochimica et biophysica acta.

[161]  Anthony E. Klon,et al.  A Detailed Molecular Belt Model for Apolipoprotein A-I in Discoidal High Density Lipoprotein* , 1999, The Journal of Biological Chemistry.

[162]  J. Fruchart,et al.  High-density lipoprotein subclasses and apolipoprotein A-I. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[163]  P. Axelsen,et al.  The Structure of Human Lipoprotein A-I , 1999, The Journal of Biological Chemistry.

[164]  P. Bondarenko,et al.  Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. , 1999, Journal of lipid research.

[165]  J. Engler,et al.  Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[166]  James C. Phillips,et al.  Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks. , 1997, Biophysical journal.

[167]  R. Krauss,et al.  Quantification of HDL2 and HDL3 cholesterol by the Vertical Auto Profile-II (VAP-II) methodology. , 1997, Journal of lipid research.

[168]  P. Duchateau,et al.  Apolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the Pancreas , 1997, The Journal of Biological Chemistry.

[169]  J. Kane,et al.  Isolation of subpopulations of high density lipoproteins: three particle species containing apoE and two species devoid of apoE that have affinity for heparin. , 1997, Journal of lipid research.

[170]  S. Wright,et al.  Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. , 1997, The Journal of clinical investigation.

[171]  M. Folin,et al.  Apolipoprotein AI isoforms in serum determined by isoelectric focusing and immunoblotting , 1997, Electrophoresis.

[172]  G. Getz,et al.  HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease. , 1996, Journal of lipid research.

[173]  J. Taylor,et al.  Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice. , 1996, Journal of lipid research.

[174]  B. Perret,et al.  Identification and quantification of diacylglycerols in HDL and accessibility to lipase. , 1996, Journal of lipid research.

[175]  P. Barter,et al.  The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. , 1995, The Journal of biological chemistry.

[176]  R. Aebersold,et al.  Characterization of human serum amyloid A protein isoforms separated by two‐dimensional electrophoresis by liquid chromatography/electrospray ionization tandem mass spectrometry , 1996, Electrophoresis.

[177]  E. Ninio,et al.  PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[178]  W. J. Johnson,et al.  Effects of Acceptor Particle Size on the Efflux of Cellular Free Cholesterol (*) , 1995, The Journal of Biological Chemistry.

[179]  G. Anantharamaiah,et al.  Structural models of human apolipoprotein A-I. , 1995, Biochimica et biophysica acta.

[180]  J. Fruchart,et al.  Non-enzymatic glycosylation of apolipoprotein A-I and its functional consequences. , 1995, Diabete & metabolisme.

[181]  M. Wurfel,et al.  Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS , 1994, The Journal of experimental medicine.

[182]  S. Harvey,et al.  The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. , 1994, Advances in protein chemistry.

[183]  J. Hoeg,et al.  O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins. , 1993, The Journal of biological chemistry.

[184]  D. Sparks,et al.  The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior. , 1992, The Journal of biological chemistry.

[185]  D. Atkinson,et al.  Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. , 1992, Biophysical journal.

[186]  R. Krauss,et al.  Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. , 1992, Clinical chemistry.

[187]  A. Jonas,et al.  Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins. , 1990, The Journal of biological chemistry.

[188]  A. Jonas,et al.  Structure of apolipoprotein A-I in three homogeneous, reconstituted high density lipoprotein particles. , 1990, The Journal of biological chemistry.

[189]  S. Mao,et al.  Purification and characterization of apolipoprotein J. , 1990, The Journal of biological chemistry.

[190]  D. G. Ferguson,et al.  A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. , 1990, The Journal of biological chemistry.

[191]  R. Brasseur,et al.  Mode of assembly of amphipathic helical segments in model high-density lipoproteins. , 1990, Biochimica et biophysica acta.

[192]  M. Hussain,et al.  Intracellular modification of human apolipoprotein AII (apoAII) and sites of apoAII mRNA synthesis: comparison of apoAII with apoCII and apoCIII isoproteins. , 1990, Biochemistry.

[193]  A. Tall,et al.  Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. , 1990, The Journal of clinical investigation.

[194]  S. Hajduk,et al.  Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein. , 1989, The Journal of biological chemistry.

[195]  A. Jonas,et al.  Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. , 1989, The Journal of biological chemistry.

[196]  V. Zannis,et al.  Mutagenesis of the glycosylation site of human ApoCIII. O-linked glycosylation is not required for ApoCIII secretion and lipid binding. , 1988, The Journal of biological chemistry.

[197]  D Hochstrasser,et al.  Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma. , 1988, Journal of lipid research.

[198]  W. Mcconathy,et al.  Distribution of lipids and apolipoproteins in human plasma by vertical spin ultracentrifugation. , 1986, Archives of biochemistry and biophysics.

[199]  G. Coetzee,et al.  Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. , 1986, The Journal of biological chemistry.

[200]  T. Forte,et al.  [26] Electron microscopy of negatively stained lipoproteins , 1986 .

[201]  T. Forte,et al.  Electron microscopy of negatively stained lipoproteins. , 1986, Methods in enzymology.

[202]  A. Jonas.  Reconstitution of high-density lipoproteins. , 1986, Methods in enzymology.

[203]  R. Krauss,et al.  Nondenaturing polyacrylamide gradient gel electrophoresis. , 1986, Methods in enzymology.

[204]  A. Gotto,et al.  Origin of apolipoprotein A-I polymorphism in plasma. , 1985, The Journal of biological chemistry.

[205]  G. Franceschini,et al.  Effects of storage on the distribution of high density lipoprotein subfractions in human sera. , 1985, Journal of lipid research.

[206]  P. Nestel,et al.  Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph. , 1985, The Journal of clinical investigation.

[207]  C. Bisgaier,et al.  Distribution of apolipoprotein A-IV in human plasma. , 1985, Journal of lipid research.

[208]  A. Jonas,et al.  Reaction of lecithin: cholesterol acyltransferase with micellar substrates. Effect of particle sizes. , 1984, Biochimica et biophysica acta.

[209]  J. Gordon,et al.  Biosynthesis of human preproapolipoprotein A-II. , 1983, The Journal of biological chemistry.

[210]  L. Dory,et al.  Characterization of dog peripheral lymph lipoproteins: the presence of a disc-shaped "nascent" high density lipoprotein. , 1983, Journal of lipid research.

[211]  E. Gong,et al.  Characterization of discoidal complexes of phosphatidylcholine, apolipoprotein A-I and cholesterol by gradient gel electrophoresis. , 1983, Biochimica et biophysica acta.

[212]  K. Sletten,et al.  Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). , 1982, Clinical and experimental immunology.

[213]  G. Miller,et al.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. , 1982, Journal of lipid research.

[214]  E. Benditt,et al.  Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions. , 1982, The Journal of biological chemistry.

[215]  J. Albers,et al.  Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II. , 1982, Journal of lipid research.

[216]  A. Jonas,et al.  Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. , 1982, The Journal of biological chemistry.

[217]  S. Goldstein,et al.  A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. , 1981, Journal of lipid research.

[218]  A. Katz,et al.  Isoproteins of human apolipoprotein A-I demonstrated in plasma and intestinal organ culture. , 1980, The Journal of biological chemistry.

[219]  H. Hauser,et al.  Structure of High Density Lipoproteins , 1980 .

[220]  J. Weinstein,et al.  High‐density lipoprotein recombinants: evidence for a bicycle tire micelle structure obtained by neutron scattering and electron microscopy , 1979, FEBS letters.

[221]  S. Olofsson,et al.  Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. , 1978, Biochemistry.

[222]  H. Brewer,et al.  The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins. , 1978, Biochemical and biophysical research communications.

[223]  N. Eriksen,et al.  Amyloid protein SAA is associated with high density lipoprotein from human serum. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[224]  A. Mclachlan,et al.  Repeated helical pattern in apolipoprotein-A-I , 1977, Nature.

[225]  B. Shen,et al.  Structure of human serum lipoproteins inferred from compositional analysis. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[226]  J. Segrest.  Amphipathic helixes and plasma lipoproteins: thermodynamic and geometric considerations. , 1977, Chemistry and physics of lipids.

[227]  R. Bradshaw,et al.  Structure of high density lipoprotein. The immunologic reactivities of the COOH- and NH2-terminal regions of apolipoprotein A-I. , 1976, The Journal of biological chemistry.

[228]  C. Sardet,et al.  Structure of human serum lipoproteins in solution. II. Small-angle x-ray scattering study of HDL3 and LDL. , 1976, Journal of molecular biology.

[229]  V. Luzzati,et al.  Structure of human serum lipoproteins in solution. I. Theory and techniques of an x-ray scattering approach using solvents of variable density. , 1976, Journal of molecular biology.

[230]  C. Sardet,et al.  Structure of human serum lipoproteins in solution. II. Small-angle x-ray scattering study of HDL and LDL. , 1976, Journal of molecular biology.

[231]  G. Utermann.  Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very-low-density lipoproteins: apolipoprotein E. , 1975, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[232]  D. Atkinson,et al.  The structure of a high density lipoprotein (HDL3) from porcine plasma , 1974, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[233]  A. Gotto,et al.  A molecular theory of lipid—protein interactions in the plasma lipoproteins , 1974, FEBS letters.

[234]  P. Laggner,et al.  Studies on the structure of lipoprotein a of human high density lipoprotein HDL3: The spherically averaged electron density distribution , 1973, FEBS letters.

[235]  A. Jonas.  Studies on the structure of bovine serum high density lipoprotein using covalently bound fluorescent probes. , 1972, The Journal of biological chemistry.

[236]  A. Scanu,et al.  On the subunit structure of the protein of human serum high density lipoprotein. I. A study of its major polypeptide component (Sephadex, fraction 3). , 1972, The Journal of biological chemistry.

[237]  H. Brewer,et al.  Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[238]  J. Gofman,et al.  Ultracentrifugal analysis of serum lipoproteins. , 1954, Methods of biochemical analysis.